|
 |
|
È޹̶óÁÖ40mg(¾Æ´Þ¸®¹«¸¿,À¯ÀüÀÚÀçÁ¶ÇÕ)(Ææ) Humira inj. 40mg
|
Àü¹®ÀǾàǰ | »èÁ¦ | ½Å¾à
|
¼öÀÔÀǾàǰ
|
|
 |
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
|
¹«»öÅõ¸íÇÑ À¯¸®¿ë±â¿¡ °ÅÀÇ ¹«»öÅõ¸íÇÑ ¾×ÀÌ ÃæÀüµÇ¾î ÀÖ´Â ÁÖ»çħÀÌ ºÎÂøµÈ ÇÁ¸®Çʵå½Ã¸°Áö ¶Ç´Â ÇÁ¸®Çʵå½Ã¸°Áö°¡ ³»ºÎ¿¡ ÀåÂøµÈ ÆæÇü |
|
|
|
|
|
Á¦Á¶È¸»ç |
Abbott
|
ÆÇ¸Åȸ»ç |
Çѱ¹¾Öºêºñ(ÁÖ)
|
Çã°¡Á¤º¸ |
Á¤»ó
(2006.07.19)
|
BIT ¾àÈ¿ºÐ·ù |
°üÀý¿° ¹× ·ù¸¶Æ¼½º Æ÷ÇÔ ±Ù°ñ°Ý°è¾à¹°(Musculoskeletal drugs including arthritis and rheumatic diseases)
|
º¹ÁöºÎºÐ·ù |
439[±âŸÀÇ Á¶Á÷¼¼Æ÷ÀÇ Ä¡·á ¹× Áø´Ü ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
624900101 \0 ¿ø/0.8mL/Ææ(2021.11.01)(ÇöÀç¾à°¡)\277,123 ¿ø/0.8mL/Ææ(2021.06.07) (º¯°æÀü¾à°¡)
|
|
|
ATCÄÚµå |
Adalimumab / L04AB04 |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]

|
÷°¡Á¦ |
±¸¿¬»ê,
±¸¿¬»ê³ªÆ®·ý(¹«¼ö¹°),
¸¸´ÏÅç,
¼ö»êȳªÆ®·ý,
¿°È³ªÆ®·ý,
À̼ÒÇÁ·ÎÆÇ¿Ã¾×(ÀÏȸ¿ë),
ÀλêÀ̼ö¼Ò³ªÆ®·ý,
ÀλêÀϼö¼Ò³ªÆ®·ý,
ÁÖ»ç¿ë¼ö,
ÁÖ»çħ,
Æú¸®¼Ò¸£º£ÀÌÆ®80
|
|
|
|
|
 |
|
|
|
|
Ç× ¸ñ |
³» ¿ë |
|
|
|
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2024-02-14 |
|
|
|
|
|
|
|
|